Focused-ultrasound developer InSightec announced that its ExAblate 2000 system has received the European CE Mark certification for pain palliation of bone metastases.
The MR-guided focused ultrasound (MRgFUS) system is currently used to treat uterine fibroids, according to the Haifa, Israel-based firm.
By AuntMinnie.com staff writers
June 7, 2007
Related Reading
InSightec nets Canadian approval, March 12, 2007
InSightec nets FDA clearance for new software, March 5, 2007
FDA clears InSightec's ExAblate 2000 for GE 3T MRI, March 1, 2007
InSightec raises $15 million, August 10, 2006
InSightec to bring Exablate to Australia, Taiwan, June 21, 2006
Copyright © 2007 AuntMinnie.com